EBOS Group Ltd
NZX:EBO
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
NZ |
EBOS Group Ltd
NZX:EBO
|
6.7B NZD | 23.8 | ||
US |
Mckesson Corp
NYSE:MCK
|
71.7B USD | 23.9 | ||
US |
Cencora Inc
NYSE:COR
|
44.3B USD | 23.9 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
23.8B USD | 43.1 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD | 24.1 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
70.4B HKD | 7.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
58.7B CNY | 21.7 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.7B EUR | 49.4 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
53.7B CNY | 14.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.